GEORGE A. LOPEZ - 12 May 2022 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Director
Signature
By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D.
Issuer symbol
ICUI
Transactions as of
12 May 2022
Transactions value $
$4,467,256
Form type
4
Filing time
13 May 2022, 16:55:44 UTC
Previous filing
14 Sep 2021
Next filing
21 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Purchase $765K +4.48K +1.75% $170.79 260K 12 May 2022 Direct F1
transaction ICUI Common Stock Purchase $847K +4.92K +1.89% $172.24 265K 12 May 2022 Direct F2
transaction ICUI Common Stock Purchase $1.23M +7.09K +2.68% $173.07 272K 12 May 2022 Direct F3
transaction ICUI Common Stock Purchase $1.62M +9.33K +3.43% $174.17 281K 12 May 2022 Direct F4
transaction ICUI Common Stock Purchase $2.97K +17 +0.01% $174.66 281K 12 May 2022 Direct F5
holding ICUI Common Stock 887K 12 May 2022 by Partnership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $170.42 to $171.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F2 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $171.64 to $172.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F3 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $172.64 to $173.61, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F4 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $173.64 to $174.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F5 All shares sold were purchased at the exact price disclosed.